Receptor tyrosine kinases in sinonasal undifferentiated carcinomas--evaluation for EGFR, c-KIT, and HER2/neu...

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Background:

• Sinonasal undifferentiated carcinoma (SNUC) is a rare and aggressive malignancy.
• Understanding the molecular profile of SNUC is crucial for targeted therapy development.

Purpose of the Study:

• To investigate the expression of epidermal growth factor receptor (EGFR), c-KIT (CD117), and HER2/neu in SNUC.
• To determine if c-KIT overexpression in SNUC is associated with activating mutations or gene amplification.

Main Methods:

• Immunohistochemistry was used to assess the expression of EGFR, c-KIT, and HER2/neu in SNUC tissue samples.
• High-resolution DNA melting curve analysis and fluorescence in situ hybridization (FISH) were employed to detect c-KIT mutations and gene amplification.

Main Results:

• c-KIT was expressed in 81.8% of SNUC cases examined.
• EGFR was detected in 27.3% of cases, while HER2/neu was not found.
• No activating mutations or gene amplification of c-KIT were identified in the assessable tumors.

Conclusions:

• c-KIT is frequently expressed in SNUC, suggesting its potential role in the tumor's biology.
• The overexpression of c-KIT in SNUC is not driven by activating mutations or gene amplification.
• These findings highlight the need for further investigation into the mechanisms of c-KIT expression in SNUC.